Two Sigma Securities, LLC

SEC CIK: 0001450144
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

RARE holding history

Ultragenyx Pharmaceutical Inc. in every 13F filed by Two Sigma Securities, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RARE overview All 13F holders of RARE Full Q2 2026 holdings

Shares (Q4 2025): 0; Sold out in Q4 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2021

Holdings of RARE by Two Sigma Securities, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2025	0	$0	0.0%	−10,875−100.0%	Sold out	Holders
Q3 2025	10,875	$327.1K	<0.1%	+10,875	New	Holders
Q3 2021	0	$0	0.0%	−2,139−100.0%	Sold out	Holders
Q2 2021	2,139	$204.0K	0.1%	+2,139	New	Holders